CD2AP is a potential prognostic biomarker of renal clear cell carcinoma.

Can ChenJia XuJie-Xin ZhangLin-Yuan ChenYu-Ang WeiWei-Ming ZhangPeng-Fei ShaoHua-Guo Xu

Published in: Cancer medicine (2024)

Taken together, our results suggest that CD2AP can be used as a diagnostic and prognostic biomarker in ccRCC patients and that DNA hypermethylation plays an important role in reducing CD2AP expression.

Keyphrases

transcription factor
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
nk cells
poor prognosis
prognostic factors
peritoneal dialysis
single molecule
long non coding rna
patient reported